BONK / FDUSD

BONK / USDC

BONK / TRY

BONK / BRL

DOGS / IDR

DOGS / USDC

DOGS / USDT

DOGS / TRY

DOGS / FDUSD

PEPE / USDT

EDEN / FDUSD

OG / BTC

CVX / USDC

CVX / USDT

OG / USDT

OG / TRY

HOLO / BNB

XPL / BNB

HOLO / FDUSD

XPL / FDUSD

ESPRIT STONES LIMITED

ROBUST HOTELS LIMITED

SILVER TOUCH TECHNO LTD

SHALIM PAINTS LTD

BPL LTD

SHIVALIC POWER CONTROL L

KRITI NUTRIENTS LIMITED

REMUS PHARMACEUTICALS L

INFOBEANS TECHNO. LTD.

SJVN LTD

MULTI COMMODITY EXCHANGE

VINEET LABORATORIES LTD

TOURISM FINANCE CORP. OF

CUPID LIMITED

SNEHAA ORGANICS LIMITED

KIRI INDUSTRIES LIMITED

VIVIMED LABS LIMITED

INNOMET ADVANCED MATERI L

KONSTELEC ENGINEERS LTD

ASPINWALL & CO LTD

Click here to get full coverage on Biocon buys out Viatris and others from biosimilar subsidiary - Fierce Pharma

Biocon buys out Viatris and others from biosimilar subsidiary  Fierce Pharma

Biocon buys out Viatris and others from biosimilar subsidiary - Fierce Pharma

Click here to get full coverage on Biocon employee jumps from company building in Bengaluru - The Economic Times

Biocon employee jumps from company building in Bengaluru  The Economic Times

Biocon employee jumps from company building in Bengaluru - The Economic Times

Click here to get full coverage on Bengaluru shocker: 26-year-old Biocon employee dies after jumping from office building - Times of India

Bengaluru shocker: 26-year-old Biocon employee dies after jumping from office building  Times of India

Bengaluru shocker: 26-year-old Biocon employee dies after jumping from office building - Times of India

Click here to get full coverage on Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited - PR Newswire

Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited  PR Newswire

Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited - PR Newswire

Click here to get full coverage on Viatris signs agreements with Biocon on $815m stake sale - Pharmaceutical Technology

Viatris signs agreements with Biocon on $815m stake sale  Pharmaceutical Technology

Viatris signs agreements with Biocon on $815m stake sale - Pharmaceutical Technology

Click here to get full coverage on 26-year-old Biocon employee falls to death from fifth floor in Bengaluru, probe on | Bengaluru - Hindustan Times

26-year-old Biocon employee falls to death from fifth floor in Bengaluru, probe on | Bengaluru  Hindustan Times

26-year-old Biocon employee falls to death from fifth floor in Bengaluru, probe on | Bengaluru - Hindustan Times

Click here to get full coverage on Biocon employee falls to death from building in Bengaluru; suicide suspected - Deccan Herald

Biocon employee falls to death from building in Bengaluru; suicide suspected  Deccan Herald

Biocon employee falls to death from building in Bengaluru; suicide suspected - Deccan Herald

Click here to get full coverage on Biocon Employee, 26, Found Dead At Bengaluru Office - NDTV

Biocon Employee, 26, Found Dead At Bengaluru Office  NDTV

Biocon Employee, 26, Found Dead At Bengaluru Office - NDTV

Click here to get full coverage on Viatris announces agreement to monetize equity stake in Biocon Biologics - Drug Store News

Viatris announces agreement to monetize equity stake in Biocon Biologics  Drug Store News

Viatris announces agreement to monetize equity stake in Biocon Biologics - Drug Store News

Click here to get full coverage on Biocon employee in Bengaluru falls to death from office building, police suspect suicide - The Indian Express

Biocon employee in Bengaluru falls to death from office building, police suspect suicide  The Indian Express

Biocon employee in Bengaluru falls to death from office building, police suspect suicide - The Indian Express

Click here to get full coverage on Biocon employee falls from 5th floor at Bengaluru campus, dies; Kiran Mazumdar-Shaw says she is shocked - livemint.com

Biocon employee falls from 5th floor at Bengaluru campus, dies; Kiran Mazumdar-Shaw says she is shocked  livemint.com

Biocon employee falls from 5th floor at Bengaluru campus, dies; Kiran Mazumdar-Shaw says she is shocked - livemint.com

Click here to get full coverage on US proposal to halve biosimilar development costs for India's Biocon, top exec says - Reuters

US proposal to halve biosimilar development costs for India's Biocon, top exec says  Reuters

US proposal to halve biosimilar development costs for India's Biocon, top exec says - Reuters

Click here to get full coverage on Biocon opens first US manufacturing facility in New Jersey - NJBIZ

Biocon opens first US manufacturing facility in New Jersey  NJBIZ

Biocon opens first US manufacturing facility in New Jersey - NJBIZ

Click here to get full coverage on Indian Tycoon Kiran Mazumdar-Shaw’s Biocon Buyout Deal Values Biologics Unit At $5.5 Billion - Forbes

Indian Tycoon Kiran Mazumdar-Shaw’s Biocon Buyout Deal Values Biologics Unit At $5.5 Billion  Forbes

Indian Tycoon Kiran Mazumdar-Shaw’s Biocon Buyout Deal Values Biologics Unit At $5.5 Billion - Forbes

Click here to get full coverage on Biocon Limited to integrate Biocon Biologics - The Pharma Letter

Biocon Limited to integrate Biocon Biologics  The Pharma Letter

Biocon Limited to integrate Biocon Biologics - The Pharma Letter

Click here to get full coverage on Inclusive innovation: how Biocon brought biotech to all - Impact Economist

Inclusive innovation: how Biocon brought biotech to all  Impact Economist

Inclusive innovation: how Biocon brought biotech to all - Impact Economist

Click here to get full coverage on Biocon Biologics Secures Global Rights To Commercialise Biosimilar Aflibercept Yesafili - BW Healthcare World

Biocon Biologics Secures Global Rights To Commercialise Biosimilar Aflibercept Yesafili  BW Healthcare World

Biocon Biologics Secures Global Rights To Commercialise Biosimilar Aflibercept Yesafili - BW Healthcare World

Click here to get full coverage on Biocon Inaugurates First US Manufacturing Facility in Cranbury - New Jersey Business Magazine

Biocon Inaugurates First US Manufacturing Facility in Cranbury  New Jersey Business Magazine

Biocon Inaugurates First US Manufacturing Facility in Cranbury - New Jersey Business Magazine

Click here to get full coverage on Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey - PR Newswire

Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey  PR Newswire

Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey - PR Newswire

Click here to get full coverage on Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options - PR Newswire

Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options  PR Newswire

Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options - PR Newswire

Click here to get full coverage on Biocon launches first US manufacturing facility in Cranbury, NJ - Investment Monitor

Biocon launches first US manufacturing facility in Cranbury, NJ  Investment Monitor

Biocon launches first US manufacturing facility in Cranbury, NJ - Investment Monitor

Click here to get full coverage on ‘We Have Been Forward Looking’: Biocon Biologics On Not Following The Keytruda Biosimilar Hype - Citeline News & Insights

‘We Have Been Forward Looking’: Biocon Biologics On Not Following The Keytruda Biosimilar Hype  Citeline News & Insights

‘We Have Been Forward Looking’: Biocon Biologics On Not Following The Keytruda Biosimilar Hype - Citeline News & Insights

Click here to get full coverage on Biocon Moves to Fully Own Biologics Unit Valued at $5.5 Billion - Bloomberg.com

Biocon Moves to Fully Own Biologics Unit Valued at $5.5 Billion  Bloomberg.com

Biocon Moves to Fully Own Biologics Unit Valued at $5.5 Billion - Bloomberg.com

Click here to get full coverage on Watch Biocon Biologics CEO Discusses Merger and IPO Plans - Bloomberg.com

Watch Biocon Biologics CEO Discusses Merger and IPO Plans  Bloomberg.com

Watch Biocon Biologics CEO Discusses Merger and IPO Plans - Bloomberg.com

Click here to get full coverage on Samsung Biologics, Amgen and Biocon invest in US pharma sites - Yahoo Finance

Samsung Biologics, Amgen and Biocon invest in US pharma sites  Yahoo Finance

Samsung Biologics, Amgen and Biocon invest in US pharma sites - Yahoo Finance

Click here to get full coverage on Biocon Biologics appoints Deepak Dobriyal as global talent and HR lead - People Matters - HR News

Biocon Biologics appoints Deepak Dobriyal as global talent and HR lead  People Matters - HR News

Biocon Biologics appoints Deepak Dobriyal as global talent and HR lead - People Matters - HR News

Click here to get full coverage on Biocon Challenges Regeneron Over UK Retinal Pharma Patent - Law360

Biocon Challenges Regeneron Over UK Retinal Pharma Patent  Law360

Biocon Challenges Regeneron Over UK Retinal Pharma Patent - Law360

Click here to get full coverage on Biocon Limited Price Targets Raised After Rebound - Volatility Index Analysis & Free Phenomenal Capital Appreciation - earlytimes.in

Biocon Limited Price Targets Raised After Rebound - Volatility Index Analysis & Free Phenomenal Capital Appreciation  earlytimes.in

Biocon Limited Price Targets Raised After Rebound - Volatility Index Analysis & Free Phenomenal Capital Appreciation - earlytimes.in

Click here to get full coverage on Biocon Biologics And Civica Team To Launch Private-Label Insulin Glargine In The U.S. - Miami Herald

Biocon Biologics And Civica Team To Launch Private-Label Insulin Glargine In The U.S.  Miami Herald

Biocon Biologics And Civica Team To Launch Private-Label Insulin Glargine In The U.S. - Miami Herald

Click here to get full coverage on Bullish Divergence Spotted in Natural Biocon (India) Limited Momentum - Covered Call Writing & Build Winning Portfolio - bollywoodhelpline.com

Bullish Divergence Spotted in Natural Biocon (India) Limited Momentum - Covered Call Writing & Build Winning Portfolio  bollywoodhelpline.com

Bullish Divergence Spotted in Natural Biocon (India) Limited Momentum - Covered Call Writing & Build Winning Portfolio - bollywoodhelpline.com

Click here to get full coverage on Biocon employee, 26, jumps to death from 5th floor of Bengaluru office building - India Today

Biocon employee, 26, jumps to death from 5th floor of Bengaluru office building  India Today

Biocon employee, 26, jumps to death from 5th floor of Bengaluru office building - India Today

Click here to get full coverage on Health Canada approves Biocon's Yesafili, biosimilar to Eylea - Ophthalmology Times

Health Canada approves Biocon's Yesafili, biosimilar to Eylea  Ophthalmology Times

Health Canada approves Biocon's Yesafili, biosimilar to Eylea - Ophthalmology Times

Click here to get full coverage on Biocon employee jumps to death from 5th floor of his office in Bengaluru - BW Police World

Biocon employee jumps to death from 5th floor of his office in Bengaluru  BW Police World

Biocon employee jumps to death from 5th floor of his office in Bengaluru - BW Police World

Click here to get full coverage on Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars - Yahoo Finance

Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars  Yahoo Finance

Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars - Yahoo Finance

Click here to get full coverage on Biocon Biologics And Civica Bring Lower-Cost Insulin Glargine To U.S. Patients - lamag.com

Biocon Biologics And Civica Bring Lower-Cost Insulin Glargine To U.S. Patients  lamag.com

Biocon Biologics And Civica Bring Lower-Cost Insulin Glargine To U.S. Patients - lamag.com

Click here to get full coverage on Would You Accumulate or Wait on Natural Biocon (India) Limited (543207) - bollywoodhelpline.com

Would You Accumulate or Wait on Natural Biocon (India) Limited (543207)  bollywoodhelpline.com

Would You Accumulate or Wait on Natural Biocon (India) Limited (543207) - bollywoodhelpline.com

Click here to get full coverage on Biocon to merge biologics unit in $5.5 billion deal - Times of India

Biocon to merge biologics unit in $5.5 billion deal  Times of India

Biocon to merge biologics unit in $5.5 billion deal - Times of India

Click here to get full coverage on Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars - Yahoo Finance

Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars  Yahoo Finance

Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars - Yahoo Finance

Click here to get full coverage on Has Biocon Limited Stock Bottomed Out Recovery Potential Reviewed - Market Profile Overview & Discover Your Financial Freedom Formula - earlytimes.in

Has Biocon Limited Stock Bottomed Out Recovery Potential Reviewed - Market Profile Overview & Discover Your Financial Freedom Formula  earlytimes.in

Has Biocon Limited Stock Bottomed Out Recovery Potential Reviewed - Market Profile Overview & Discover Your Financial Freedom Formula - earlytimes.in

Click here to get full coverage on ‘I am shocked’: Biocon chief Kiran Mazumdar-Shaw expresses condolences after employee falls to death from fifth floor | India News - Hindustan Times

‘I am shocked’: Biocon chief Kiran Mazumdar-Shaw expresses condolences after employee falls to death from fifth floor | India News  Hindustan Times

‘I am shocked’: Biocon chief Kiran Mazumdar-Shaw expresses condolences after employee falls to death from fifth floor | India News - Hindustan Times

Click here to get full coverage on USFDA issues EIR for Biocon Generics Cranbury facility - Medical Dialogues

USFDA issues EIR for Biocon Generics Cranbury facility  Medical Dialogues

USFDA issues EIR for Biocon Generics Cranbury facility - Medical Dialogues

Click here to get full coverage on Biocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept worldwide - Medical Dialogues

Biocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept worldwide  Medical Dialogues

Biocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept worldwide - Medical Dialogues

Click here to get full coverage on Amgen Expands US BPCIA Denosumab Litigation to include Biocon - Pearce IP

Amgen Expands US BPCIA Denosumab Litigation to include Biocon  Pearce IP

Amgen Expands US BPCIA Denosumab Litigation to include Biocon - Pearce IP

Click here to get full coverage on Biocon Limited to Wholly Acquire Biocon Biologics, Valued at USD 5.5B - Pearce IP

Biocon Limited to Wholly Acquire Biocon Biologics, Valued at USD 5.5B  Pearce IP

Biocon Limited to Wholly Acquire Biocon Biologics, Valued at USD 5.5B - Pearce IP

Click here to get full coverage on India-based Biocon opens first U.S. manufacturing facility in Cranbury - ROI-NJ

India-based Biocon opens first U.S. manufacturing facility in Cranbury  ROI-NJ

India-based Biocon opens first U.S. manufacturing facility in Cranbury - ROI-NJ

Click here to get full coverage on How the Evolving Story Shapes Analyst Views on Biocon’s Strengths and Challenges - Yahoo Finance

How the Evolving Story Shapes Analyst Views on Biocon’s Strengths and Challenges  Yahoo Finance

How the Evolving Story Shapes Analyst Views on Biocon’s Strengths and Challenges - Yahoo Finance

Click here to get full coverage on Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO says - Reuters

Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO says  Reuters

Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO says - Reuters

Click here to get full coverage on Biocon Biologics Secures Strong Market Access Coverage for Yesintek™ in the United States Covering 100+ Million Lives - PR Newswire

Biocon Biologics Secures Strong Market Access Coverage for Yesintek™ in the United States Covering 100+ Million Lives  PR Newswire

Biocon Biologics Secures Strong Market Access Coverage for Yesintek™ in the United States Covering 100+ Million Lives - PR Newswire

Click here to get full coverage on Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States - GlobeNewswire

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States  GlobeNewswire

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States - GlobeNewswire

Click here to get full coverage on Who was Anantha Kumar? 26-year-old Biocon employee found dead on Bengaluru office campus - DNA India

Who was Anantha Kumar? 26-year-old Biocon employee found dead on Bengaluru office campus  DNA India

Who was Anantha Kumar? 26-year-old Biocon employee found dead on Bengaluru office campus - DNA India

Click here to get full coverage on Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US - Ophthalmology Times

Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US  Ophthalmology Times

Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US - Ophthalmology Times

Click here to get full coverage on Biocon Chief Kiran Mazumdar-Shaw wins USC Business Management Award - Medical Dialogues

Biocon Chief Kiran Mazumdar-Shaw wins USC Business Management Award  Medical Dialogues

Biocon Chief Kiran Mazumdar-Shaw wins USC Business Management Award - Medical Dialogues

Click here to get full coverage on Biocon to merge biologics unit; to acquire stake held by Serum, Mylan - The Hindu

Biocon to merge biologics unit; to acquire stake held by Serum, Mylan  The Hindu

Biocon to merge biologics unit; to acquire stake held by Serum, Mylan - The Hindu

Click here to get full coverage on S&P Global places Biocon Biologics on positive CreditWatch on account of accelerated debt reduction - Medical Dialogues

S&P Global places Biocon Biologics on positive CreditWatch on account of accelerated debt reduction  Medical Dialogues

BIOCON

Price Chart

Key Statistics

Technicals

About BIOCON

Latest News

Biocon buys out Viatris and others from biosimilar subsidiary - Fierce Pharma

Biocon employee jumps from company building in Bengaluru - The Economic Times

Bengaluru shocker: 26-year-old Biocon employee dies after jumping from office building - Times of India

Advanced Charts

Top Gainers

Top Losers